| Total Score | People Score | Events Score |
|---|---|---|
| 16 | 14 | 14 |
| Date | Event | Presentation | Speakers |
|---|---|---|---|
| March 19, 2014 | 3rd Neurological Biomarkers | A post-GWAS Method for Translating Statistical Associations to Disease-relevant Pathways | Allen Roses |
| May 31, 2013 | ASCO Annual Meeting 2013 | Special Session | Catherine Wang |
| April 6, 2013 | AACR Annual Meetings | From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA | Dashyant Dhanak |
| From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC | Tona M Gilmer, Axel Hoos | ||
| February 10, 2013 | 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs | Plenary: Repurposing Compounds for CNS Targets: Utilizing Translational Bioinformatics | Pankaj Agarwal |
| September 3, 2012 | Ourense Conference on Imaging Mass Spectrometry | Observing Directly the Distribution of an Inhaled Domain Antibody in Healthy and Infected Mice by MALDI MS Imaging | Peter S. Marshall |
| February 26, 2011 | Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) | Immunotherapy: Helping the Host | TLR4 Agonists Facilitate “Rapid Acting Vaccine” Against the Respiratory Tract Pathogen, Influenza A | Jory R. Baldridge |
| February 26, 2011 | Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) | Immunity in Respiratory Tract (X6) | TLR4 Agonists Facilitate “Rapid Acting Vaccine” Against the Respiratory Tract Pathogen, Influenza A | Jory R. Baldridge |
| February 12, 2011 | Cancer Control by Tumor Suppressors and Immune Effectors (J8) | Cancer Vaccines: Prophylaxy or Therapy | Development of the MAGE-A3 ASCI: From Tumor Specificity to Predictive Biomarkers | Vincent G Brichard |
| September 23, 2009 | TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis | An Effective Framework for Omic Data Analysis | Jie J. Cheng |
| January 26, 2009 | 7th Annual Partnering with Central Labs | B1 : How to Reduce the Burden on Smaller Sponsor Clinical Team-The Cross Functional Approach | Karen Turner |
| March 30, 2008 | Nuclear Receptors: Steroid Sisters | Drug Development | Dennis Sprecher |
| March 30, 2008 | Nuclear Receptors: Orphan Brothers | Drug Development | Dennis Sprecher |
| March 25, 2008 | RNAi, MicroRNA, and Non-Coding RNA | MicroRNAs and Their Targets (Plants and Invertebrates) | Eric C Lai |
| October 11, 2007 | Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) | SELECTING LEADS AND DETECTING ADVERSE ACTIVITY (14:00-17:30) | Dana E. Vanderwall |
| SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Analysis of Biological Mechanism of Action, and Characterization of Profiles across the Progression Path (14:05-14:35) | Dana E. Vanderwall |
How We Rank